Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial

BACKGROUND: Acute promyelocytic leukemia (APL) is a highly curable disease when treated with all-trans retinoid acid (ATRA) and arsenic trioxide (ATO). The combination of ATO and ATRA has become the standard therapeutic protocol for induction therapy in non-high-risk APL. An oral arsenic realgar-ind...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Trials
Asıl Yazarlar: Zhang, Xinxin, Liu, Li, Yao, Yazhou, Gong, Sha, Wang, Mengchang, Xi, Jieying, Chen, Limei, Wei, Suhua, Zhang, Huiyun, Zhao, Chenyang, Wang, Huaiyu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Study Protocol
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6941314/
https://ncbi.nlm.nih.gov/pubmed/31898521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3983-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller